pubmed-article:20143779 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20143779 | lifeskim:mentions | umls-concept:C0000970 | lld:lifeskim |
pubmed-article:20143779 | lifeskim:mentions | umls-concept:C0014898 | lld:lifeskim |
pubmed-article:20143779 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:20143779 | lifeskim:mentions | umls-concept:C0531004 | lld:lifeskim |
pubmed-article:20143779 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:20143779 | lifeskim:mentions | umls-concept:C1657294 | lld:lifeskim |
pubmed-article:20143779 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:20143779 | lifeskim:mentions | umls-concept:C1961132 | lld:lifeskim |
pubmed-article:20143779 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:20143779 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:20143779 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:20143779 | pubmed:dateCreated | 2010-3-4 | lld:pubmed |
pubmed-article:20143779 | pubmed:abstractText | Fatty acid amide hydrolase (FAAH) is the key hydrolytic enzyme for the endogenous cannabinoid receptor ligand anandamide. The synthesis and evaluation for their FAAH inhibitory activities of a series of 18 paracetamol esters are described. Structure-activity relationship studies indicated that the ester (33) with a 2-(4-(2-(trifluoromethyl)pyridin-4-ylamino)phenyl)acetic acid substituent was the most potent analogue in this series. The compound inhibited FAAH activity in a competitive manner with a K(i) value of 0.16 microM. The compound was also able to inhibit the FAAH activity in rat basophilic leukemia cells as assessed by measuring either the hydrolysis of anandamide, the FAAH-dependent cellular accumulation of anandamide, or the FAAH-dependent recycling of tritium to the cell membranes. The compound also inhibited the activity of monoacylglycerol lipase (MGL), the enzyme responsible for the hydrolysis of the endogenous cannabinoid receptor ligand 2-arachidonoylglycerol, with an IC(50) value of 1.9 microM. It is concluded that the compound may be a useful template for the design of potent novel inhibitors of FAAH. | lld:pubmed |
pubmed-article:20143779 | pubmed:language | eng | lld:pubmed |
pubmed-article:20143779 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20143779 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20143779 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20143779 | pubmed:month | Mar | lld:pubmed |
pubmed-article:20143779 | pubmed:issn | 1520-4804 | lld:pubmed |
pubmed-article:20143779 | pubmed:author | pubmed-author:CongiuCenzoC | lld:pubmed |
pubmed-article:20143779 | pubmed:author | pubmed-author:OnnisValentin... | lld:pubmed |
pubmed-article:20143779 | pubmed:author | pubmed-author:FowlerChristo... | lld:pubmed |
pubmed-article:20143779 | pubmed:author | pubmed-author:HempelFranzis... | lld:pubmed |
pubmed-article:20143779 | pubmed:author | pubmed-author:BjörklundEmme... | lld:pubmed |
pubmed-article:20143779 | pubmed:author | pubmed-author:SöderströmEmm... | lld:pubmed |
pubmed-article:20143779 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20143779 | pubmed:day | 11 | lld:pubmed |
pubmed-article:20143779 | pubmed:volume | 53 | lld:pubmed |
pubmed-article:20143779 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20143779 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20143779 | pubmed:pagination | 2286-98 | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:meshHeading | pubmed-meshheading:20143779... | lld:pubmed |
pubmed-article:20143779 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20143779 | pubmed:articleTitle | Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors. | lld:pubmed |
pubmed-article:20143779 | pubmed:affiliation | Department of Toxicology, Unit of Medicinal Chemistry, University of Cagliari, via Ospedale 72, Cagliari I-09124, Italy. vonnis@unica.it | lld:pubmed |
pubmed-article:20143779 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20143779 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:20143779 | lld:chembl |